BlockBeats News, January 31st, NEO founder Da Hongfei stated that he and fellow founder Erik Zhang have agreed to end their dispute, which was harmful to both NEO and the community. They are currently busy preparing financial reports, with the goal of releasing a comprehensive preview by February 15th. This preview will provide detailed information for financial verification, budget planning, and governance reform. Regular updates will be provided before the final version is released.
Previously, the two founders of Neo had a falling out, with Da Hongfei accused of failing to fulfill financial disclosure commitments and Erik being accused of monopolizing Foundation financial rights.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.





Key Takeaways Bybit plans to introduce “MyBank” dollar accounts in partnership with licensed financial institutions, enhancing seamless conversion…










Latest Crypto Market Snapshot as of August 22, 2025 BTC Soars to $115,250.00 ETH Hits $4,450.75 XRP Climbs…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.














Key Takeaways Bybit plans to introduce “MyBank” dollar accounts in partnership with licensed financial institutions, enhancing seamless conversion…